Publication
Article
Pharmacy Times
A recent study conducted at Turku University in Finland highlights the urgency of early and aggressive treatment of rheumatoid arthritis (RA). The study examined the impact of delaying treatment for symptoms on whether disease remission is achieved; it also assessed the efficacy of single-drug therapy vs combination therapy. Researchers found that those in the group whose treatment was delayed fared worst, whereas those who received an aggressive combination-therapy regimen fared best.